PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2012 | 15 | 2 |
Tytuł artykułu

Screening for cholinesterase inhibitors in selected fruits and vegetables

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Wydawca
-
Rocznik
Tom
15
Numer
2
Opis fizyczny
http://www.ejpau.media.pl
Twórcy
autor
  • Department of Biotechnology, Human Nutrition and Science of Food Commodities, Lublin University of Natural Sciences, 20-704 Lublin, Poland
autor
Bibliografia
  • 1. Adsersen A., Gauguin B., Gudiksen L., Jäger A.K., 2006. Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity. J. Ethnopharmacol. 104, 418-422. 
  • 2. Angunawela I.I., Barker A., 2001. Anticholinesterase drugs for alcoholic Korsakoff syndrome. Int. J. Geriatr. Psych. 16, 338-339.
  • 3. Ballard C.G., 2002. Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition. Eur. Neurol. 47, 64-70.
  • 4. Bartolini M., Greig N.H., Yu b Q.-S., Andrisanoa V., 2009. Immobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer's disease. J. Chromatogr. A 1216, 2730-2738.
  • 5. Bengmark S., Mesa M.D., Gil Hernández A., 2009. Plant-derived health - The effects of turmeric and curcuminoids. Nutr. Hosp. 24, 273-281.
  • 6. Bhattacharya S.K., Bhattacharya A., Kumar A., Ghosal S., 2000. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother. Res. 14, 174-179.
  • 7. Bustamam A., Ibrahim S., Al-Zubairi A.S., Met M., Syam M.M., 2008. Zerumbone: A natural compound with anti- cholinesterase activity. Am. J. Pharmacol. Toxicol. 3, 206-208.
  • 8. Chan A., Shea T.B., 2006. Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress. J. Alzheimers Dis. 10, 353-358.
  • 9. Chan A., Shea T.B., 2009. Dietary supplementation with apple juice decreases endogenous amyloid-P levels in murine brain. J. Alzheimers Dis. 16, 167-171.
  • 10. Contestabile A., 2011. The history of the cholinergic hypothesis. Behav. Brain Res. 221, 334-340.
  • 11. Coyle J., Kershaw P., 2001. Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of alzheimer's disease. Biol. Psychiat. 49, 289-299.
  • 12. Cummings J.L., 2000. Cholinesterase inhibitors: A new class of psychotropic compounds. Am. J. Psychiat. 157, 4-15.
  • 13. Cummings J.L., 2003. Use of cholinesterase inhibitors in clinical practice: Evidence-based recommendations. Am. J. Geriat. Psychiat. 11, 131-145.
  • 14. Darreh-Shori T., Forsberg A., Modiri N., Andreasen N., Blennow K., Kamil C., Ahmed H., Almkvist O., Langstrom B., Nordberg A., 2011. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiol. Aging, 32, 2320.e15-2320.e32.
  • 15. de Jong C.F., Derks R.J.E., Bruneel B., Niessen W., Irth H., 2006. High-performance liquid chromatography-mass spectrometry-based acetylcholinesterase assay for the screening of inhibitors in natural extracts. J. Chromatogr. A, 1112, 303-310.
  • 16. Ellman G.L., Lourtney D.K., Andres V., Gmelin G., 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
  • 17. Ferreira A., Proenja C., Serralheiro M.L.M., Araújo M.E.M., 2006. The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J. Ethnopharmacol. 108, 31-37.
  • 18. Fletcher S.P., Geyer B.C., Smith A., Evron T., Joshi L., Soreq H., Mor T.S., 2004. Tissue distribution of cholinesterases and anticholinesterases in native and transgenic tomato plants. Plant Mol. Biol. 55, 33-43.
  • 19. Francis P.T., Palmer A.M., Snape M., Wilcock G.K., 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatr. 66, 137-147.
  • 20. Friedman J.I., 2004. Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology 174, 45-53.
  • 21. Gholamhoseinian A., Moradi M.N., Sharifi-far F., 2009. Screening the methanol extracts of some Iranian plants for acetylcholinesterase inhibitory activity. Res. Pharm. Sci. 4, 105-112.
  • 22. Ghosal S., Lal J., Srivastava R., Bhattacharya S.K., Upadhyay S.N., Jaiswal A.K., Chattopadhyay U., 1989. Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera. Phytother. Res. 3, 201-206.
  • 23. Giacobini E., 2001. Selective inhibitors of butyrylcholinesteras: A valid alternative for therapy of Alzheimer's disease? Drug Aging 18, 891-898.
  • 24. Giacobini E., 2004. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol. Res. 50, 433-440.
  • 25. Giacobini E., Spiegel R., Enz A., Veroff A.E., Cutler N.R., 2002. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit. J. Neural Transm. 109, 1053-1065.
  • 26. Giasson B.I., Ischiropoulos H., Lee V.M.-Y., Trojanowski J.Q., 2002. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radical Bio. Med. 32, 1264-1275.
  • 27. Grutzendler J., Morris J.C., 2001. Cholinesterase inhibitors for Alzheimer's disease. Drugs 61, 41-52.
  • 28. Gupta A., Gupta R., 1997. A survey of plants for presence of cholinesterase activity. Phytochemistry 46, 827-831.
  • 29. Hadacová V., Vacková K., Klozová E., Kutácek M., Pitterová K., 1983. Cholinesterase activity in some species of the Allium genus. Biol. Plantarum (Praha) 25, 209-215.
  • 30. Heo H.J., Lee C.Y., 2005. Strawberry and its anthocyanins reduce oxidative stress-induced apoptosis in PC12 cells. J. Agr. Food Chem. 53, 1984-1989.
  • 31. Houghton P.J., Howes M.-J., 2005. Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease. NeuroSignals 14, 6-22.
  • 32. Iga J.I., Araki M., Ishimoto Y., Ohmori T., 2001. A case of Korsakoff's syndrome improved by high doses of donepezil. Alcohol Alcoholism 36, 553-555.
  • 33. Ingkaninan K., de Best C.M., van der Heijden R., Hofte A.J.P., Karabatak B., Irth H., Tjaden U.R., van der Greef J., Verpoorte R., 2000. High-performance liquid chromatography with on -line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products. J. Chromatogr. A, 872, 61-73
  • 34. Ingkaninan K., Temkitthawon P., Chuenchom K., Yuyaem T., Thongnoi W., 2003. Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies. J. Ethnopharmacol. 89, 261-264.
  • 35. Jayaprakasam B., Padmanabhan K., Nair M.G., 2010. Withanamides in Withania somnífera fruit protect PC-12 cells from P-amyloid responsible for Alzheimer's disease. Phytother. Res. 24, 859-863.
  • 36. Joseph J.A., Fisher D.R., Carey A.N., 2004. Fruit extracts antagonize Amyloid beta- or DA-induced deficits in Ca2+ flux in M1 -transfected COS-7 cells. J. Alzheimer's Dis. 6, 403-411.
  • 37. Kahkonen M.P., Hopia AT, Vuorela H.J., Rauha J.-P., Pihlaja K., Kujala T.S., Heinonen M., 1999. Antioxidant activity of plant extracts containing phenolic compound. J. Agr. Food Chem. 47, 3954-3962.
  • 38. Kamal M.A., Klein P., Luo W., Li Y., Holloway H.W., Tweedie D., Greig N.H., 2008. Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine. Neurochem. Res. 33, 745-753.
  • 39. Kim Y.-K., Koo B.-S., Gong D.-J., Lee Y.-C., Ko J.-H., Kim C.-H., 2003. Comparative effect of Prunus persica L. BATSCH-water extract and tacrine (9-amino-1,2,3,4-tetrahydroacridine hydrochloride) on concentration of extracellular acetylcholine in the rat hippocampus. J. Ethnopharmacol. 87, 149-154.
  • 40. Kishnani P.S., Sullivan J.A., Walter B.K., Spiridigliozzi G.A., Doraiswamy P.M., Krishnan K.R.R., 1999. Cholinergic therapy for Down's syndrome. Lancet 353, 1064-1065.
  • 41. Kozurkova M., Hamulakova S., Gazova Z., Paulikova H., Kristian P., 2011. Neuroactive multifunctional tacrine congeners with cholinesterase, anti-amyloid aggregation and neuroprotective properties. Pharmaceuticals 4, 382-418.
  • 42. Kuca K., Jun D., Cabal J., Hrabinova M., Bartosova L., Opletalova V., 2006. Russian VX: inhibition and reactivation of acetylcholinesterase compared with VX agent. Basic Clin. Pharmacol. Toxicol. 98, 389-394.
  • 43. Kumar S., Maheshwari K.K., Singh V., 2009. Protective effects of Punica granatum seeds extract against aging and scopolamine induced cognitive impairments in mice. Afr. J. Trad. Comp. Alt. Med. 6, 49-56.
  • 44. Kwak H.-M., Jeon S.-Y., Sohng B.-H., Kim J.-G., Lee J.-M., Lee K.-B., Jeong H.-H., Hur J.-M., Kang Y.-H., Song K.-S., 2005. P-secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch. Pharm. Res. 28, 1328-1332.
  • 45. Lee B., Choi Y., Kim H., Kim S.Y., Hahm D.H., Lee H.J., Shim I., 2003. Protective effects of methanol extract of Acori graminei rhizoma and Uncariae Ramulus et Uncus on ischemia-induced neuronal death and cognitive impairments in the rat. Life Sci. 74, 435-450.
  • 46. Lin C.C., Cheng W.L., Hsu S.H., Chang C.M., 2003. The effects of Ginkgo biloba extracts on the memory and motor functions of rats with chronic cerebral insufficiency. Neuropsychobiology 47, 47-51.
  • 47. Martorana A., Esposito Z., Koch G., 2010. Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? CNS Neurosci. Ther. 16, 235-245.
  • 48. McGehee D.S., Krasowski M.D., Fung D.L., Wilson B., Gronert G.A., Moss J., 2000. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism. Anesthesiology 93, 510-519.
  • 49. Mesulam M.-M., Guillozet A., Shaw P., Levey A., Duysenc E.G., Lockridge O., 2002. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110, 627-639.
  • 50. Mesulam M.-M., Guillozet A., Shaw P., Quinn B., 2002. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol. Dis. 9, 88-93.
  • 51. Mohamed T., Rao P.P.N., 2010. Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors. Bioorg. Med. Chem. Lett. 20, 3606-3609.
  • 52. Mukherjee P.K., Kumar V., Mal M., Houghton P.J., 2007. Acetylcholinesterase inhibitors from plants. Phytomedicine 14, 289-300.
  • 53. Muralidharan M., Soreq H., Mor T.S., 2005. Characterizing pea acetylcholinesterase. Chem. Biol. Interact. 157-158, 406¬407.
  • 54. Nicolodi M., Galeotti N., Ghelardini C., Bartolini A., Sicuteri F., 2002. Central cholinergic challenging of migraine by testing second-generation anticholinesterase drugs. Headache 42, 596-602.
  • 55. Nordberg A., Svensson A.-L., 1998. Cholinesterase inhibitors in the treatment of Alzheimer's disease. A comparison of tolerability and pharmacology. Drug Safety 19, 465-480.
  • 56. Obón J.M., Díaz-García M.C., Castellar M.R., 2011. Red fruit juice quality and authenticity control by HPLC. J. Food Compos. Anal. 24, 760-771.
  • 57. Orhan I., §ener B., Choudhary M.I., Khalid A., 2004. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J. Ethnopharmacol. 91, 57-60.
  • 58. Ortiz D., Shea T.B., 2004. Apple juice prevents oxidative stress induced by amyloid-beta in culture. J. Alzheimers Dis. 6, 27-30.
  • 59. Park C.H., Choi S.H., Koo J.W., Seo J.H., Kim H.S., Jeong S.J., Suh Y.H., 2002. Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-11. J. Neurosci. Res. 70, 484-492.
  • 60. Park S.-Y., Kim H.-S., Hong S.S., Sul D., Hwang K.W., Lee D., 2009. The neuroprotective effects of traditional oriental herbal medicines against P-amyloid-induced toxicity. Pharm. Biol. 47, 976-981.
  • 61. Peñarrieta J.M., Alvarado J.A., Bergenstáhl B., Ákesson B., 2009. Total antioxidant capacity and content of phenolic compounds in wild strawberries (Fragaria vesca) collected in Bolivia. Int. J. Fruit Sci. 9, 344-359.
  • 62. Peng Y., Sun J., Hon S., Nylander A.N., Xia W., Feng Y., Wang X., Lemere C.A., 2010. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-P in a transgenic model of Alzheimer's disease. J. Neurosci. 30, 8180-8189.
  • 63. Podoly E., Shalev D.E., Shenhar-Tsarfaty S., Bennett E.R., Assayag E.B., Wilgus H., Livnah O., Soreq H., 2009. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology. J. Biol. Chem. 284, 17170-17179.
  • 64. Rahman M.M., Ichiyanagi T., Komiyama T., Hatano Y., KonishiT., 2006. Superoxide radical- and peroxynitrite-scavenging activity of anthocyanins; structure-activity relationship and their synergism. Free Radical Res. 40, 993-1002.
  • 65. Rai K.S., Murthy K.D., Karanth K.S., Nalini K., Rao M.S., Srinivasan K.K., 2002. Clitoria ternatea root extract enhances acetylcholine content in rat hippocampus. Fitoterapia 73, 685-689.
  • 66. Ramirez M.R., Izquierdo I., Raseira M.C.B., Zuanazzi J.A., Barros D., Henriques A.T., 2005. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol. Res. 52, 457-462.
  • 67. Rao A.A., Sridhar G.R., Das U.N., 2007. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Med. Hyphoteses 69, 1272-1276.
  • 68. Rhee I.K., van de Meent M., Ingkaninan K., Verpoorte R., 2001. Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. J. Chromatogr. A 915, 217-223.
  • 69. Rickard N.S., Kowadlo N., Gibbs M.E., 2001. Effect of the Ginkgo biloba extract, EGb 761, on memory formation in day-old chicks. Pharmacol. Biochem. Be. 69, 351-358.
  • 70. Shen Z.X., 2004. Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease. Med. Hypotheses 63, 308-318.
  • 71. Shukitt-Hale B., Lau F.C., Joseph J.A., 2008. Berry fruit supplementation and the aging brain. J. Agr. Food Chem. 56, 636-641.
  • 72. Slatkin N.E., Rhiner M., Bolton T.M., 2001. Donepezil in the treatment of opioid-induced sedation: Report of six cases. J. Pain Symptom Manag. 21, 425-438.
  • 73. Small D.H., Michaelson S., Sberna G., 1996. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28, 453-483.
  • 74. Suh G.-H., Ryu S.-H., Lee D.-W., Han C., Ju Y.-S., Kee B.S., Lee J.-N., Bae J.N., Choi J.-H., Kim D.-J., Lee N.-J., Lee J.-Y., Go H.-J., Yi J.-S., Cho S.-J., Jeon Y.-W., 2011. Cholinesterase inhibitors for alzheimer disease: Do they provide more than symptomatic benefits? Am. J. Geriat. Psychiat. 19, 266-273.
  • 75. Suh S.-J., Koo B.-S., Jin U.-H., Hwang M.-J., Lee In-S., Kim C.-H., 2006. Pharmacological characterization of orally active cholinesterase inhibitory activity of Prunuspersica L. Batsch in Rats. J. Mol. Neurosci. 29, 101-108.
  • 76. Szwajgier D., Borowiec K., 2012. Phenolic acids from malt are efficient acetylcholinesterase and butyrylcholinesterase inhibitors. J. I. Brewing 118, 40-48.
  • 77. Tretyn A., Kendrick R.E., 1991. Acetylcholine in plants: presence, metabolism and mechanism of action. Bot. Rev. 57, 33-73.
  • 78. VanDenBerg C.M., Kazmi Y., Jann M.W., 2000. Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly. Drug. Aging 16, 123-138.
  • 79. Vinutha B., Prashanth D., Salma K., Sreeja S.L., Pratiti D., Padmaja R., Radhika S., Amit A., Venkateshwarlu K., Deepak M., 2007. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J. Ethnopharmacol. 109, 359-363.
  • 80. Wang R., Yan H., Tang X., 2006. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin. 27, 1-26.
  • 81. Weinstock M., 1999. Selectivity of cholinesterase inhibition. Clinical implications for the treatment of Alzheimer's disease. CNS Drugs 12, 307-313.
  • 82. Whelan F.J., Walker M.S., Schultz S.K., 2000. Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Ann. Clin. Psychiatr. 12, 131-135.
  • 83. Wiśniewska J., Tretyn A., 2003. Acetylcholinesterase activity in Lycopersicon esculentum and its phytochrome mutants. Plant Physiol. Bioch. 41, 711-717.
  • 84. Wolosiak R., Worobiej E., Piecyk M., Druzynska B., Nowak D., Lewicki P. P., 2010. Activities of amine and phenolic antioxidants and their changes in broad beans (Viciafaba) after freezing and steam cooking. Int. J. FoodSci. Tech. 45, 29-37.
  • 85. Yabe T., Tuchida H., Kiyohara H., Takeda T., Yamada H., 2003. Induction of NGF synthesis in astrocytes by onjisaponins of Polygala tenuifolia, constituents of kampo (Japanese herbal) medicine, Ninjin-yoei-to. Phytomedicine 10, 106-114.
  • 86. Youm J.W., Jeon J.H., Kim H., Kim Y.H., Ko K., Joung H., Ki H., 2008. Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease. Biotechnol. Lett. 30, 1839-1845.
  • 87. Zga N., Papastamoulis Y., Toribio A., Richard T., Delaunay J.C., Jeandet P., Renault J.H., Monti J. P., Merillon J. M., Waffo-Teguo P., 2009. Preparative purification of antiamyloidogenic stilbenoids from Vitis vinifera (Chardonnay) stems by centrifugal partition chromatography. J. Chromatogr. B 877, 1000-1004.
  • 88. Zhang Z.-J., 2004. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci. 75, 1659-1699.
  • 89. Zhang Z.Q., Yuan L., Yang M., Luo Z.P., Zhao Y.M., 2002. The effect of Morinda officinalis How, a Chinese traditional medicinal plant, on the DRL 72-s schedule in rats and the forced swimming test in mice. Pharmacol. Biochem. Be. 72, 39-43.
  • 90. Zheng W., Wang S.Y., 2003. Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries. J. Agr. Food Chem. 51, 502-509.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-7f0d0f6f-d8ea-47fe-9d67-2387d3ae106d
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.